Navigation Links
First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes

th consecutive year, Science magazine named AstraZeneca a "Top Employer" on its ranking of the world's most respected biopharmaceutical employers.

AstraZeneca Forward-Looking Statement

The statements herein include forward-looking statements. By their nature, forward-looking statements and forecasts involve risk and uncertainty. For a discussion of those risks and uncertainties please see the company's Annual Report/Form 20-F for 2006.

For more information about Bristol-Myers Squibb, please visit: www.bms.com.

For more information about AstraZeneca, please visit: www.astrazeneca-us.com.

CONTACT: Media, David M. Rosen of Bristol-Myers Squibb +1-609-252-5675 or(pager) +1-866-308-4484, , or David Albaugh ofAstraZeneca, +1-302-886-7098 or (cell) +1-609-304-3445,; Investors, John Elicker of Bristol-MyersSquibb, +1-212-546-3775, , or Mina Blair ofAstraZeneca, +44-20-7304-5084, david.m.rosen@bms.com david.albaugh@astrazeneca.com john.elicker@bms.com mina.blair@astrazeneca.com

Web site: http://www.bms.com/http://www.astrazeneca-us.com//

Ticker Symbol: (NYSE:BMY),(NYSE:AZN)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
4. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
5. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
6. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
7. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
8. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
9. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
10. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
11. Dasatinib Shows High Early Response Rate as First Treatment for Chronic Myelogenous Leukemia, M. D. Anderson Researchers Report
Post Your Comments:
(Date:11/21/2014)... 21, 2014 In September 2014, the staff ... out a new product development plan that started with ... edition" lab coat , aptly named "Vera G.," ... in the world. The new women,s designer lab coat ... a sleek envelope collar, vertical princess and high waist ...
(Date:11/21/2014)... , Nov. 21, 2014  World Hemp Oil, an ... THC, announces they are now offering legal, organic oil ... Web type strains grown in medical marijuana states. People ... disorders, such as Parkinson,s, MS, and spinal cord injury, ... to pass, because imported CBD Oil Is legal in ...
(Date:11/21/2014)... , Nov. 21, 2014  Abaxis, Inc. (NasdaqGS: ... instruments and consumables for the medical, research, and veterinary ... veterinary and research markets in the United ... stock purchase agreement to acquire 100% of QCR & ... based distribution organization. The transaction closed on November ...
Breaking Medicine Technology:Medelita Introduces Medical Industry's First Limited Edition Women's Designer Lab Coat 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 3Abaxis Acquires UK-based Distribution Organization 2Abaxis Acquires UK-based Distribution Organization 3Abaxis Acquires UK-based Distribution Organization 4
... 26, 2011 Rochester Medical Corporation (NASDAQ: ROCM ... Thursday, May 5, 2011.  The Company will then hold a ... will begin at 3:30 p.m. central time (4:30 p.m. eastern ... and can be accessed at Rochester Medical,s website at ...
... CARY, N.C., April 26, 2011 Cetero ... (CRO), today announced the appointment of James "Jay" Dixon ... spent more than 25 years in the pharmaceutical, biotechnology ... to support Cetero,s objective of maintaining its market leadership ...
Cached Medicine Technology:Rochester Medical Announces Second Quarter 2011 Earnings Conference Call Thursday, May 5, 2011 2Cetero Research Names 25-Year Industry Veteran James Dixon to Head Quality and Compliance 2
(Date:11/23/2014)... 23, 2014 SWAccessControl.com's high quality access ... Recently, the company has announced its new collection of ... on these high quality power suppliers. All the new ... The special offer lasts until Dec. 20, 2014. , ... them have been supporting it for a long time. ...
(Date:11/23/2014)... 2014 The FDA is Watching: , ... On-Demand Webinar**, Dec. 11, 2014 ? Any Time at ... focus on promotional activities is no longer limited to ... looking at websites, Twitter, journal articles, TV appearances, Facebook ... Dec. 11, for On-Demand access to Timothy Ayers and ...
(Date:11/22/2014)... (PRWEB) November 23, 2014 Every year ... their communities. AlignLife experience rapid growth in the Greenville, ... very unique opportunity. AlignLife of Simpsonville will ... offices for their first annual Toy Drive. These six ... they would support with this year's toy drive. With ...
(Date:11/22/2014)... black prom dress will never go out of fashion. BellasDress.com, ... new items of black prom gowns . Now all ... up to 70% off. People throughout the world can enjoy ... made with the best materials, can make wearers feel comfortable. ... company provides these beautiful outfits in a huge range of ...
(Date:11/22/2014)... 22, 2014 “Due to my knee replacement ... from Gurnee, Ill. “While using the ice grip attachment, I ... thought there needed to be a safer way to prevent ... BLOCK. , The SPIKE BLOCK offers added safety and stability ... help to reduce injuries and damage associated with traditional spiked ...
Breaking Medicine News(10 mins):Health News:Cheap Access Control Power Supplies Online Now at SWAccessControl.com, Special Offer Until Dec. 20, 2014 2Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 2Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 3Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 4Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 5Health News:Greenville Area AlignLife Offices Join Together for a Local Toy Drive 2Health News:New Black Prom Dresses from BellasDress.com 2
... new drug targets for mucosal fungus found in most ... genetic approach to improve treatment of common infections caused by ... by researchers at Georgetown University Medical Center. , The ... Ssk1 gene could offer a new drug target against the ...
... who report receiving written and verbal instructions on the ... significantly less likely to suffer the serious gastrointestinal and ... the drug, according to new research from the University ... the October issue Journal of General Internal Medicine ...
... Breast Cancer Funding to be a National Priority, DALLAS, ... Day,the Susan G. Komen for the Cure(R) Advocacy Alliance today ... -- that features a,bipartisan collection of voters declaring "I ... us in some way, and Americans all across,the country have ...
... American National,Insurance Company (Nasdaq: ANAT ) announced a ... share) compared to net income of,$79,245,000 ($2.98 per diluted ... security investments as well as,catastrophe losses in the property ... in earnings., After tax operating earnings for the ...
... Care, Inc. (DCI),announced today that it has completed ... PANCRECARB(R) (pancrelipase), used in the treatment,of Exocrine Pancreatic ... ("FDA"). The FDA had previously granted the product ... schedule., "Digestive Care has provided vital products ...
... providing the industry,s most aggressive defense, The Doctors Company, the largest ... is rolling out litigation education retreats for member physicians who are ... ... Calif. (Vocus) October 27, 2008 -- As part of its commitment ...
Cached Medicine News:Health News:Genetic Approach Boosts Yeast Infection Treatment 2Health News:Better instructions reduce complications among patients using common blood thinner 2Health News:Better instructions reduce complications among patients using common blood thinner 3Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Unveils New 'I Vote for the Cure'(R) Web Video 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Unveils New 'I Vote for the Cure'(R) Web Video 3Health News:American National Announces Third Quarter 2008 Results 2Health News:American National Announces Third Quarter 2008 Results 3Health News:American National Announces Third Quarter 2008 Results 4Health News:Digestive Care, Inc. Announces the Complete Submission of the NDA for PANCRECARB(R) (pancrelipase) 2Health News:The Doctors Company Launches Litigation Education Retreats to Assist Physicians Involved in Medical Litigation 2
7 mm blade, angled right. Flat handle....
5 mm blade with slightly rounded tip. Round handle....
0.75 mm diameter blade. Angled 60 degrees. Round handle. Designated most popular model or size....
7 mm strong curved blade. Round handle....
Medicine Products: